Percheron Therapeutics LimitedASX: PER

ATL1103 Phase II trial results published in leading journal

May 23, 2018 at 4:17 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment